Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Aurinia Pharmaceuticals Inc. (AUPH) Profit Margins

Over the twelve months to 2026-06-30, Aurinia Pharmaceuticals Inc. (AUPH) had gross margin 90.4%, operating margin 48.4%, net margin 100.8%, free cash flow margin 56.2%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AUPHAurinia Pharmaceuticals Inc.Follow AUPH — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin————97.6%95.8%91.9%88.0%88.5%90.4%
Operating margin———-208.1%-396.3%-83.2%-52.2%-2.0%37.1%48.4%
Net margin———-204.9%-396.8%-80.7%-44.5%2.4%101.5%100.8%
FCF margin———-150.7%-346.4%-59.6%-19.5%18.8%47.8%56.2%

USD millions · SEC XBRL

Aurinia Pharmaceuticals Inc. — questions

What is Aurinia Pharmaceuticals Inc.'s gross margin?
90.4% over the twelve months to 2026-06-30.
What is Aurinia Pharmaceuticals Inc.'s operating margin?
48.4% over the twelve months to 2026-06-30.
What is Aurinia Pharmaceuticals Inc.'s net profit margin?
100.8% over the twelve months to 2026-06-30.

Every figure on this page comes from Aurinia Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.